*Editor's note: A previous version of this story incorrectly stated that Mayo Clinic's president is retiring. It has been corrected to state Mayo Clinic Health System's president is retiring.
Mayo Clinic Health System announced that its president, Bobbie Gostout, will retire at the end of this year, in today's bite-sized hospital and health industry news from Maryland, Minnesota, and New York.
- Maryland: CMS on Thursday announced that average premiums for 2021 Medicare Advantage (MA) plans likely will be 11% lower when compared with 2020 MA plans, costing an average of $21 per month for the 2021 coverage year. "This is the lowest that the average monthly premium for a [MA] plan has been since 2007," the agency said. According to CMS, 26.9 million Medicare beneficiaries are projected to enroll in MA plans for the 2021 coverage year—up from 24.4 million beneficiaries who were enrolled in 2020 MA plans (Minemyer, FierceHealthcare, 9/24; CMS release, 9/24).
- Minnesota: Mayo Clinic Health System on Thursday announced that the health system's president, Bobbie Gostout, will retire at the end of this year. Gostout, who joined Mayo Clinic 24 years ago, was the first woman to participate in system's gynecology oncology fellowship, and she later became a part of the health system's division of gynecology surgery. Before becoming Mayo's president, Gostout spent nine years as chair of the health system's department of obstetrics and gynecology (Gooch, Becker's Hospital Review, 9/24).
- New York: Gov. Andrew Cuomo (D) on Thursday announced that New York officials will review any novel coronavirus vaccines authorized for use by FDA, citing concerns over whether the agency is facing political pressure to approve an inoculation against the virus. "Frankly, I'm not going to trust the federal government's opinion," Cuomo said. Although New York officials are not involved with the federal approval process for vaccine candidates, they would have a role in determining how to distribute any authorized coronavirus vaccines throughout the state under the Trump administration's current distribution plan. As such, New York officials could decide to delay a vaccine's distribution if they deem the inoculation unsafe, the New York Times reports (Gold/McKinley, New York Times, 9/24).